Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Finished Goods (2016 - 2018)

Sanofi (SNY) has disclosed Finished Goods for 4 consecutive years, with $2.7 billion as the latest value for Q4 2018.

  • Quarterly Finished Goods rose 6.3% to $2.7 billion in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $2.7 billion through Dec 2018, up 6.3% year-over-year, with the annual reading at $2.7 billion for FY2018, 6.3% up from the prior year.
  • Finished Goods hit $2.7 billion in Q4 2018 for Sanofi, up from $2.5 billion in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $2.7 billion in Q4 2018 to a low of $2.3 billion in Q4 2015.
  • Historically, Finished Goods has averaged $2.5 billion across 4 years, with a median of $2.4 billion in 2016.
  • Biggest five-year swings in Finished Goods: grew 1.88% in 2016 and later rose 10.02% in 2017.
  • Year by year, Finished Goods stood at $2.3 billion in 2015, then grew by 1.88% to $2.3 billion in 2016, then rose by 10.02% to $2.5 billion in 2017, then grew by 6.3% to $2.7 billion in 2018.
  • Business Quant data shows Finished Goods for SNY at $2.7 billion in Q4 2018, $2.5 billion in Q4 2017, and $2.3 billion in Q4 2016.